Handbook of Photomedicine 2013
DOI: 10.1201/b15582-50
|View full text |Cite
|
Sign up to set email alerts
|

Photodynamic Therapy and Fluorescent Diagnostics in the Russian Federation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 1 publication
0
2
0
Order By: Relevance
“…Photodithazine (Fotoditazin) is the N‐dimethylglucamine salt of chlorin(e6) invented by Ponomarev Helium Vasilievich, prepared by Veta‐Grand LLC, Moscow, Russia, and has received regulatory approval in Russia . It has been mainly studied as an antimicrobial PS, but has been used in clinical trials of basal cell carcinoma of the skin and in case studies in advanced lung cancer, bladder cancer and brain tumors .…”
Section: Clinical Photosensitizers In Non‐western Countriesmentioning
confidence: 99%
See 1 more Smart Citation
“…Photodithazine (Fotoditazin) is the N‐dimethylglucamine salt of chlorin(e6) invented by Ponomarev Helium Vasilievich, prepared by Veta‐Grand LLC, Moscow, Russia, and has received regulatory approval in Russia . It has been mainly studied as an antimicrobial PS, but has been used in clinical trials of basal cell carcinoma of the skin and in case studies in advanced lung cancer, bladder cancer and brain tumors .…”
Section: Clinical Photosensitizers In Non‐western Countriesmentioning
confidence: 99%
“…It received a series of regulatory approvals in Russia between 2001 and 2008. It is used at an IV dose of 0.3–0.8 mg kg −1 , with multiple 675 nm laser irradiations delivered between 24 and 72 h postinjection each at 80–100 J cm −2 with a total up to 600 J cm −2 . It has been tested in Russian clinical trials for basal cell carcinoma, advanced lung cancer, recurrent head and neck cancer, primary or recurrent gastric cancer, cancer of the esophagus, pleural mesothelioma and breast cancer metastases .…”
Section: Clinical Photosensitizers In Non‐western Countriesmentioning
confidence: 99%